| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,799 |
13,241 |
$1.06M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,924 |
7,173 |
$436K |
| 36415 |
Collection of venous blood by venipuncture |
14,497 |
13,172 |
$49K |
| 80061 |
Lipid panel |
2,359 |
2,282 |
$28K |
| 90834 |
Psychotherapy, 45 minutes with patient |
241 |
136 |
$20K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,234 |
1,208 |
$18K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,033 |
1,955 |
$17K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
603 |
591 |
$16K |
| 80053 |
Comprehensive metabolic panel |
1,473 |
1,423 |
$15K |
| 85027 |
|
1,991 |
1,918 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,465 |
1,372 |
$11K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
104 |
99 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,282 |
1,205 |
$8K |
| 90686 |
|
489 |
484 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
486 |
477 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
55 |
52 |
$4K |
| 90791 |
Psychiatric diagnostic evaluation |
32 |
29 |
$4K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
46 |
37 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
39 |
39 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
28 |
26 |
$2K |
| G0402 |
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment |
14 |
14 |
$2K |
| 86140 |
|
550 |
502 |
$2K |
| 84460 |
|
499 |
459 |
$2K |
| 80050 |
General health panel |
42 |
42 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
121 |
118 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
209 |
183 |
$2K |
| 93793 |
|
244 |
118 |
$2K |
| 82248 |
|
370 |
353 |
$2K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
415 |
413 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
35 |
34 |
$1K |
| 84450 |
|
356 |
318 |
$1K |
| 90653 |
|
86 |
74 |
$1K |
| 82565 |
|
316 |
281 |
$1K |
| 85652 |
|
507 |
462 |
$1K |
| 90694 |
|
32 |
28 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
39 |
39 |
$960.02 |
| 99442 |
|
12 |
12 |
$941.95 |
| 92551 |
|
136 |
134 |
$834.67 |
| 86803 |
|
57 |
57 |
$821.41 |
| 82728 |
|
45 |
45 |
$677.12 |
| 82607 |
|
25 |
24 |
$413.57 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
17 |
15 |
$355.01 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13 |
13 |
$333.50 |
| 82550 |
|
62 |
52 |
$297.23 |
| 85610 |
|
57 |
38 |
$225.88 |
| 99173 |
|
159 |
158 |
$216.38 |
| 81001 |
|
52 |
51 |
$182.31 |
| 83540 |
|
29 |
27 |
$164.75 |
| 83550 |
|
16 |
14 |
$101.69 |
| 81003 |
|
17 |
17 |
$36.32 |
| X5622 |
|
60 |
58 |
$0.00 |